Clinical efficacy of an automated high-sensitivity C-reactive protein assay

Clinical Chemistry

Volumn 45, Issue 12, 1999, Pages 2136-2141

  Rifai, Nader ^a,d   Tracy, Russell P ^b   Ridker, Paul M ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTERY DISEASE; ARTICLE; AUTOMATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN DETERMINATION;

EID: 0032710356     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.12.2136     Document Type: Article

References (16)

1. 1. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997:336:973-9.
2. 2. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998;97:425-8.
3. 3. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999;99:237-42.
4. 4. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98: 731-3.
5. 5. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vase Biol 1997;17:1121-7.
6. 6. Kuller LH, Tracy RP, Shaten J, Meilahn EN, for the MRFIT Research Group. Relationship of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 1996;144:537-47.
7. 7. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997; 349:462-6.
8. 8. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 1997;43: 52-8.
9. 9. Ledue TB, Weiner DL, Sipe J, Poulin SE, Collins MF, Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A, and mannose binding protein in human serum. Ann Clin Biochem 1998;35:745-53.
10. 10. Steering Committee of the Physician's Health Study Research Group. Final report of the aspirin component of the ongoing Physician's Health Study. N Engl J Med 1989;321:129-35.
11. 11. Ridker PM, Rifai N, Sacks F, Pfeffer M, Moye LA, Goldman S, et al., for the Cholesterol and Recurrent Events (CARE) Investigators. Inflammation, Pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation 1998;98:839-44.
12. 12. Castell JV, Gomez-Lechon MJ, Fabra R, Trullenque R, Heinrich PC. Acute phase response of human hepatocytes: regulation of acute phase protein synthesis by interleukin-6. Hepatology 1990;12: 1179-86.
13. 13. Liuzzo G, Biasucci LM, Gallimore R, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24.
14. 14. Thompson S, Kienast J, Pyke S, Heverkate F, van de Loo J. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995;332: 635-41.
15. 15. Morrow DA, Rifai N, Antman EM, McCabe CH, Weiner DL, Cannon CP, Braunwald E. C-reactive protein is a potent predictor of mortality in acute coronary syndromes. A TIMI 11A substudy. J Am Coll Cardiol 1998;31:1460-5.
16. 16. Ferreiros ER, Boissonnet CP, Pizarro R, Merletti PFG, Corrado G, Cagide A, Bazzino OO. Elevated C-reactive protein at discharge is a strong independent predictor of 90 day outcome in unstable angina [Abstract]. Circulation 1998;98(Suppl l):493-4.